重大公告
OBI licensed the Intellectual Property Right of Global Aesthetic Medicine to a designated company
Contents: 1.Date of occurrence of the event: Dec 04, 2020 2.Company name: OBI Pharma Inc. 3.Relationship to the Company (please enter “head office” or “subsidiaries”): …
OBI capital increases by issuance of stocks to transfer stocks with Amaran Biotechnology Inc. (supplement base date)
1.Type of merger and acquisition (e.g. merger, spin-off, acquisition, or share transfer): Share transfer 2.Date of occurrence of the event: Nov 27, 2020 3.Names of …
OBI received the reply from FDA about the Investigational Device Exemption (IDE) of Phase I/II Cohort Expansion human clinical studies for first-in-class novel prodrug, OBI-3424
1. Date of occurrence of the event: Nov 23, 2020 2. Company name: OBI Pharma Inc. 3. Relationship to the Company (please enter “head office” …
Announcement of 2020 Q3 financial reports submitted to the board of directors
Date of the financial reports submitted to the board of directors or approved by the board of directors: Nov 06, 2020 Date of the financial …
OBI capital increases by issuance of stocks to transfer stocks with Amaran Biotechnology Inc. (the agreement of share exchange and cooperation signed, and trading counterparts designated)
1. Type of merger and acquisition (e.g. merger, spin-off, acquisition, or share transfer): Share transfer 2. Date of occurrence of the event: Oct 15, 2020 …